Structural heart disease

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants of procedural success. The TAVI-CLOSE study evaluated...
Dr. Omar Tupayachi -
CHIP LATAM News

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by...
solaci -
Canal de difusión Whatsapp eng

Featured Articles

News

Structural heart disease

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are...
Dr. Omar Tupayachi -
Structural Heart Disease

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a...
Dr. Omar Tupayachi -
Acute coronary syndromes

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances...
Dr. Omar Tupayachi -
Acute coronary syndromes

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the...
Dr. Omar Tupayachi -

Upcoming Events

Learn more

CHIP LATAM: Complications Workshop

LATAM Valves 2026

SOLACI & SBHCI 2026

SOLACI-CACI Course for Physicians

SOLACI-CACI 2026 Course for Technicians and Nurses

Institutional News

News

CHIP LATAM News

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual...
solaci -
Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology...
solaci -
Institutional News

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is...
solaci -
Institutional News

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial...
solaci -
spot_img

International Congresses

Latest Congress

AHA 2025 Scientific Sessions

Discover the most outstanding scientific articles from the AHA 2025 Congress, held from November 7 to 10, 2025, in New Orleans, United States.

Learn more
Antiplatelet

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month...
Learn More
Left Atrial Apendix Closure

AHA 2025 | CLOSURE-AF: Left Atrial Appendage Occlusion (LAAO) vs. Medical Therapy in Atrial Fibrillation with High Stroke and Bleeding Risk

Atrial fibrillation (AF) is a complex condition in which patients often present with multiple comorbidities, including high bleeding risk. Percutaneous left atrial appendage...
Learn More
Antiplatelet

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic...
Learn More

TCT 2025

Learn more

ESC 2025

Learn more

EuroPCR 2025

Learn more

ACC 2025

Learn more

SOLACI Meetings

SOLACI-SOCIME 2025 Congress

SOLACI-SOCIME 2025 Congress Certificates

Get your certificate of attendance or scientific participation

Selected Presentations

See slides selected by the editorial committee of our website

The Best Images

Find here all the photos of the event throughout its 3 days

SOLACI-SOCIME 2025 Posters

Discover and review the works presented during the SOLACI-SOCIME 2025 Congress

Day 1 Summary

Relive the main scientific activities of the first day

Day 2 Summary

Relive the main scientific activities of the second day

Day 3 Summary

Relive the main scientific activities of the third day

All the Event News

Find all the news from SOLACI-SOCIME 2025

Hilton Hotel, Buenos Aires, Argentina

SOLACI-CACI 2024

Discover the best presentations, videos, and images from SOLACI-CACI 2024, held from August 7 to 9, 2024, in Buenos Aires.

More information
Institutional News

SOLACI-CACI 2024 – Live Cases

Relive the Live Cases from the SOLACI-CACI 2024 Congress, held from August 7 to 9, 2024, at the Hilton Hotel in Buenos Aires. SOLACI-CACI...
Learn More
Institutional News

SOLACI-CACI 2024 – Presentations day 3

Discover the highlights of the third day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires,...
Learn More
Institutional News

SOLACI-CACI 2024 – Day 2 Presentations

Discover the highlights of the second day of activities of  SOLACI-CACI 2024 Congress, held from August 7 to 9 at the Hilton Hotel in Buenos Aires,...
Learn More

SOLACI-SBHCI 2023

Learn more

SOLACI-SOCIME 2022

Learn more

SOLACI-CACI 2021

Learn more

SOLACI-SBHCI 2019

Learn more

ProEducar

Educational Newsletter N° 120

Special Edition on Durability in TAVR

2025 Edition

Educational Newsletter N° 119

Special Supplement on Management and Assessment of Coronary Calcium

2024 Edition

Educational Newsletter N° 118

New Applications of Cardiac Tomography for Coronary Interventions

2023 Edition

Educational Newsletter N° 117

Extraordinary Supplement on Coronary Physiology in the Hemodynamics Laboratory

2022 Edition

Educational Webinars

Access all the virtual educational activities from SOLACI on various topics related to cardiovascular interventions.

I want to learn more!

Clinical Cases

SOLACI Peripheral

Learn more

Fellow's Corner

Learn more

SOLACI Areas

SOLACI Sessions

More Information

SOLACI Peripheral

More Information

CHIP LATAM

More Information

ProEducar

More Information

MIL Group

More Information

Congenital Heart Disease

More Information

SOLACI Research

More Information

SOL SOLACI

More Information

Nurses and Technicians

More Information

Most Read Articles

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

Dr. Omar Tupayachi - 0
The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

Dr. Omar Tupayachi - 0
As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

Dr. Omar Tupayachi - 0
In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

Dr. Omar Tupayachi - 0
The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Dr. Andrés Rodríguez - 0
Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Dr. Juan Manuel Pérez - 0
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

solaci - 0
The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...